Suppr超能文献

中国Castleman 病大样本患者的肾脏受累情况。

Renal involvement in a large cohort of Chinese patients with Castleman disease.

机构信息

Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Beijing, China

出版信息

Nephrol Dial Transplant. 2012 Oct;27 Suppl 3:iii119-25. doi: 10.1093/ndt/gfr245. Epub 2011 May 19.

Abstract

BACKGROUND

The association of kidney disease with Castleman disease (CD) is uncommon. To date, most studies have been based on single-case reports. Here, we describe renal involvement in CD in a large Chinese cohort.

METHODS

Seventy-six CD patients were identified in one clinical center. Clinical and pathological characteristics of patients with renal involvement were described, which were also compared with cases identified through a systematic literature review.

RESULTS

Nineteen patients (25%) exhibited renal involvement. Patients with multicentric clinical type (59 versus 0%) or plasma cell (PC)/mixed cellularity histological variant (61.5 versus 6%) were more likely to have renal involvement (P < 0.001). Proteinuria (with 7/19 reaching nephrotic range) and acute renal failure (12/19, 63%) were the main clinical presentations. Kidney biopsy revealed various glomerular diseases (10/11) and interstitial nephritis (1/11), while with 'thrombotic microangiopathy-like' lesions were the most common pathological characteristics (6/11, 55%). This contrasted significantly with the literature in which amyloidosis was the most reported. Renal outcomes responded well to chemotherapy. Nine (9/12, 75%) patients with acute renal failure recovered completely, one recovered partially. Overall, only three (3/19, 16%) patients progressed to end-stage kidney disease. Renal involvement did not influence survival rate (log-rank test, P = 0.73) in the follow-up.

CONCLUSIONS

CD with multicentric type and PC or mixed cellularity variant are often associated with renal complications. Thrombotic microangiopathy-like lesions are the most common pathological characteristics. Chemotherapy can reverse kidney damage in most cases.

摘要

背景

肾脏疾病与 Castleman 病(CD)的关联并不常见。迄今为止,大多数研究都是基于单个病例报告。在此,我们描述了一个大型中国队列中 CD 患者的肾脏受累情况。

方法

在一个临床中心确定了 76 名 CD 患者。描述了有肾脏受累的患者的临床和病理特征,并与系统文献复习中确定的病例进行了比较。

结果

19 名患者(25%)存在肾脏受累。多中心临床型(59%比 0%)或浆细胞(PC)/混合细胞型组织学变异型(61.5%比 6%)的患者更有可能发生肾脏受累(P<0.001)。蛋白尿(19 例中有 7 例达到肾病范围)和急性肾衰竭(19 例中有 12 例,63%)是主要的临床表现。肾脏活检显示各种肾小球疾病(11 例中的 10 例)和间质性肾炎(11 例中的 1 例),而“血栓性微血管病样”病变是最常见的病理特征(11 例中的 6 例,55%)。这与文献报道的淀粉样变性形成鲜明对比。肾脏结局对化疗反应良好。急性肾衰竭的 9 例(12 例中的 9 例,75%)患者完全恢复,1 例部分恢复。总的来说,只有 3 例(19 例中的 3 例,16%)患者进展为终末期肾病。肾脏受累在随访中并未影响生存率(对数秩检验,P=0.73)。

结论

多中心型和 PC 或混合细胞型 CD 常伴有肾脏并发症。血栓性微血管病样病变是最常见的病理特征。大多数情况下,化疗可逆转肾脏损伤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验